98
Views
441
CrossRef citations to date
0
Altmetric
Article

Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development

, , , , , , , , , , & show all
Pages 5015-5022 | Received 20 Dec 2005, Accepted 20 Apr 2006, Published online: 27 Mar 2023

REFERENCES

  • Argraves, K. M., B. A. Wilkerson, W. S. Argraves, P. A. Fleming, L. M. Obeid, and C. J. Drake. 2004. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J. Biol. Chem. 279:50580–50590.
  • Argraves, W. S., and C. J. Drake. 2005. Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 286:875–884.
  • Bachner, D., M. Ahrens, N. Betat, D. Schroder, and G. Gross. 1999. Developmental expression analysis of murine autotaxin (ATX). Mech. Dev. 84:121–125.
  • Baumforth, K. R., J. R. Flavell, G. M. Reynolds, G. Davies, T. R. Pettit, W. Wei, S. Morgan, T. Stankovic, Y. Kishi, H. Arai, M. Nowakova, G. Pratt, J. Aoki, M. J. Wakelam, L. S. Young, and P. G. Murray. 2005. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood 106:2138–2146.
  • Boucharaba, A., C. M. Serre, S. Gres, J. S. Saulnier-Blache, J. C. Bordet, J. Guglielmi, P. Clezardin, and O. Peyruchaud. 2004. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J. Clin. Investig. 114:1714–1725.
  • Carvalho, R. L., L. Jonker, M. J. Goumans, J. Larsson, P. Bouwman, S. Karlsson, P. T. Dijke, H. M. Arthur, and C. L. Mummery. 2004. Defective paracrine signalling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131:6237–6247.
  • Clair, T., J. Aoki, E. Koh, R. W. Bandle, S. W. Nam, M. M. Ptaszynska, G. B. Mills, E. Schiffmann, L. A. Liotta, and M. L. Stracke. 2003. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 63:5446–5453.
  • Clair, T., H. Y. Lee, L. A. Liotta, and M. L. Stracke. 1997. Autotaxin is an exoenzyme possessing 5′-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J. Biol. Chem. 272:996–1001.
  • Copp, A. J. 1995. Death before birth: clues from gene knockouts and mutations. Trends Genet. 11:87–93.
  • Dennis, J., L. Nogaroli, and B. Fuss. 2005. Phosphodiesterase-Iα/autotaxin (PD-Iα/ATX): a multifunctional protein involved in central nervous system development and disease. J. Neurosci. Res. 82:737–742.
  • Ferry, G., E. Tellier, A. Try, S. Gres, I. Naime, M. F. Simon, M. Rodriguez, J. Boucher, I. Tack, S. Gesta, P. Chomarat, M. Dieu, M. Raes, J. P. Galizzi, P. Valet, J. A. Boutin, and J. S. Saulnier-Blache. 2003. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J. Biol. Chem. 278:18162–18169.
  • Fuss, B., H. Baba, T. Phan, V. K. Tuohy, and W. B. Macklin. 1997. Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J. Neurosci. 17:9095–9103.
  • George, E. L., E. N. Georges-Labouesse, R. S. Patel-King, H. Rayburn, and R. O. Hynes. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119:1079–1091.
  • Gijsbers, R., J. Aoki, H. Arai, and M. Bollen. 2003. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett. 538:60–64.
  • Goding, J. W., B. Grobben, and H. Slegers. 2003. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim. Biophys. Acta 1638:1–19.
  • Gu, J. L., S. Muller, V. Mancino, S. Offermanns, and M. I. Simon. 2002. Interaction of G α12 with G α13 and G αq signaling pathways. Proc. Natl. Acad. Sci. USA 99:9352–9357.
  • Hama, K., J. Aoki, M. Fukaya, Y. Kishi, T. Sakai, R. Suzuki, H. Ohta, T. Yamori, M. Watanabe, J. Chun, and H. Arai. 2004. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 279:17634–17639.
  • Hoelzinger, D. B., L. Mariani, J. Weis, T. Woyke, T. J. Berens, W. S. McDonough, A. Sloan, S. W. Coons, and M. E. Berens. 2005. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7–16.
  • Ilic, D., Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura, J. Fujimoto, M. Okada, and T. Yamamoto. 1995. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377:539–544.
  • Ishii, I., N. Fukushima, X. Ye, and J. Chun. 2004. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73:321–354.
  • Jansen, S., C. Stefan, J. W. Creemers, E. Waelkens, A. Van Eynde, W. Stalmans, and M. Bollen. 2005. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J. Cell Sci. 118:3081–3089.
  • Kehlen, A., N. Englert, A. Seifert, T. Klonisch, H. Dralle, J. Langner, and C. Hoang-Vu. 2004. Expression, regulation and function of autotaxin in thyroid carcinomas. Int. J. Cancer 109:833–838.
  • Kingsbury, M. A., S. K. Rehen, J. J. Contos, C. M. Higgins, and J. Chun. 2003. Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat. Neurosci. 6:1292–1299.
  • Kranenburg, O., M. Poland, F. P. van Horck, D. Drechsel, A. Hall, and W. H. Moolenaar. 1999. Activation of RhoA by lysophosphatidic acid and Gα12/13 subunits in neuronal cells: induction of neurite retraction. Mol. Biol. Cell 10:1851–1857.
  • Lee, H. Y., J. Murata, T. Clair, M. H. Polymeropoulos, R. Torres, R. E. Manrow, L. A. Liotta, and M. L. Stracke. 1996. Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem. Biophys. Res. Commun. 218:714–719.
  • Liliom, K., G. Sun, M. Bunemann, T. Virag, N. Nusser, D. L. Baker, D. A. Wang, M. J. Fabian, B. Brandts, K. Bender, A. Eickel, K. U. Malik, D. D. Miller, D. M. Desiderio, G. Tigyi, and L. Pott. 2001. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem. J. 355:189–197.
  • Liu, Y., R. Wada, T. Yamashita, Y. Mi, C. X. Deng, J. P. Hobson, H. M. Rosenfeldt, V. E. Nava, S. S. Chae, M. J. Lee, C. H. Liu, T. Hla, S. Spiegel, and R. L. Proia. 2000. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Investig. 106:951–961.
  • Mills, G. B., and W. H. Moolenaar. 2003. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3:582–591.
  • Mizugishi, K., T. Yamashita, A. Olivera, G. F. Miller, S. Spiegel, and R. L. Proia. 2005. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25:11113–11121.
  • Moolenaar, W. H., L. A. van Meeteren, and B. N. Giepmans. 2004. The ins and outs of lysophosphatidic acid signaling. Bioessays 26:870–881.
  • Nam, S. W., T. Clair, C. K. Campo, H. Y. Lee, L. A. Liotta, and M. L. Stracke. 2000. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 19:241–247.
  • Nam, S. W., T. Clair, Y. S. Kim, A. McMarlin, E. Schiffmann, L. A. Liotta, and M. L. Stracke. 2001. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res. 61:6938–6944.
  • Nieuw Amerongen, G. P., M. A. Vermeer, and V. W. van Hinsbergh. 2000. Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler. Thromb. Vasc. Biol. 20:E127–E133.
  • Offermanns, S., V. Mancino, J. P. Revel, and M. I. Simon. 1997. Vascular system defects and impaired cell chemokinesis as a result of Gα13 deficiency. Science 275:533–536.
  • Panetti, T. S., D. F. Hannah, C. Avraamides, J. P. Gaughan, C. Marcinkiewicz, A. Huttenlocher, and D. F. Mosher. 2004. Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid. J. Thromb. Haemost. 2:1645–1656.
  • Postma, F. R., K. Jalink, T. Hengeveld, S. Offermanns, and W. H. Moolenaar. 2001. Gα13 mediates activation of a depolarizing chloride current that accompanies RhoA activation in both neuronal and nonneuronal cells. Curr. Biol. 11:121–124.
  • Ruppel, K. M., D. Willison, H. Kataoka, A. Wang, Y. W. Zheng, I. Cornelissen, L. Yin, S. M. Xu, and S. R. Coughlin. 2005. Essential role for Gα13 in endothelial cells during embryonic development. Proc. Natl. Acad. Sci. USA 102:8281–8286.
  • Saulnier-Blache, J. S., A. Girard, M. F. Simon, M. Lafontan, and P. Valet. 2000. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J. Lipid Res. 41:1947–1951.
  • Schaft, J., R. Ashery-Padan, F. van der Hoeven, P. Gruss, and A. F. Stewart. 2001. Efficient FLP recombination in mouse ES cells and oocytes. Genesis 31:6–10.
  • Schmidt, A., and A. Hall. 2002. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 16:1587–1609.
  • Schulze, C., C. Smales, L. L. Rubin, and J. M. Staddon. 1997. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J. Neurochem. 68:991–1000.
  • Siess, W., and G. Tigyi. 2004. Thrombogenic and atherogenic activities of lysophosphatidic acid. J. Cell. Biochem. 92:1086–1094.
  • Stassar, M. J., G. Devitt, M. Brosius, L. Rinnab, J. Prang, T. Schradin, J. Simon, S. Petersen, A. Kopp-Schneider, and M. Zoller. 2001. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br. J. Cancer 85:1372–1382.
  • Stefan, C., S. Jansen, and M. Bollen. 2005. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem. Sci. 30:542–550.
  • Stracke, M. L., H. C. Krutzsch, E. J. Unsworth, A. Arestad, V. Cioce, E. Schiffmann, and L. A. Liotta. 1992. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 267:2524–2529.
  • Su, A. I., M. P. Cooke, K. A. Ching, Y. Hakak, J. R. Walker, T. Wiltshire, A. P. Orth, R. G. Vega, L. M. Sapinoso, A. Moqrich, A. Patapoutian, G. M. Hampton, P. G. Schultz, and J. B. Hogenesch. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA 99:4465–4470.
  • Tokumura, A., E. Majima, Y. Kariya, K. Tominaga, K. Kogure, K. Yasuda, and K. Fukuzawa. 2002. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277:39436–39442.
  • Umezu-Goto, M., Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G. B. Mills, K. Inoue, J. Aoki, and H. Arai. 2002. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158:227–233.
  • van der Weyden, L., D. J. Adams, L. W. Harris, D. Tannahill, M. J. Arends, and A. Bradley. 2005. Null and conditional semaphorin 3B alleles using a flexible puroDeltatk loxP/FRT vector. Genesis 41:171–178.
  • Van Leeuwen, F. N., C. Olivo, S. Grivell, B. N. Giepmans, J. G. Collard, and W. H. Moolenaar. 2003. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J. Biol. Chem. 278:400–406.
  • van Meeteren, L. A., F. Frederiks, B. N. Giepmans, M. F. Pedrosa, S. J. Billington, B. H. Jost, D. V. Tambourgi, and W. H. Moolenaar. 2004. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. J. Biol. Chem. 279:10833–10836.
  • van Meeteren, L. A., P. Ruurs, E. Christodoulou, J. W. Goding, H. Takakusa, K. Kikuchi, A. Perrakis, T. Nagano, and W. H. Moolenaar. 2005. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J. Biol. Chem. 280:21155–21161.
  • Wu, W. T., C. N. Chen, C. I. Lin, J. H. Chen, and H. Lee. 2005. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. Endocrinology 146:3387–3400.
  • Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242–248.
  • Yang, S. Y., J. Lee, C. G. Park, S. Kim, S. Hong, H. C. Chung, S. K. Min, J. W. Han, H. W. Lee, and H. Y. Lee. 2002. Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin. Exp. Metastasis 19:603–608.
  • Ye, X., K. Hama, J. J. Contos, B. Anliker, A. Inoue, M. K. Skinner, H. Suzuki, T. Amano, G. Kennedy, H. Arai, J. Aoki, and J. Chun. 2005. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435:104–108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.